Phase II study of cis-diamminedichloroplatinum (NSC-119875) in advanced carcinoma of the large bowel.
about
Statistical design considerations for pilot studies transitioning therapies from the bench to the bedsideRisk factors for cisplatin-induced nephrotoxicity and potential of magnesium supplementation for renal protection.Prediction of nephrotoxicity induced by cisplatin combination chemotherapy in gastric cancer patientsEvaluation of single-agent therapy in human colorectal tumour xenografts.Renal toxicity and chemotherapy in children with cancer.Drug-induced peripheral neuropathies.
P2860
Phase II study of cis-diamminedichloroplatinum (NSC-119875) in advanced carcinoma of the large bowel.
description
1973 nî lūn-bûn
@nan
1973年の論文
@ja
1973年学术文章
@wuu
1973年学术文章
@zh
1973年学术文章
@zh-cn
1973年学术文章
@zh-hans
1973年学术文章
@zh-my
1973年学术文章
@zh-sg
1973年學術文章
@yue
1973年學術文章
@zh-hant
name
Phase II study of cis-diammine ...... carcinoma of the large bowel.
@en
Phase II study of cis-diamminedichloroplatinum
@nl
type
label
Phase II study of cis-diammine ...... carcinoma of the large bowel.
@en
Phase II study of cis-diamminedichloroplatinum
@nl
prefLabel
Phase II study of cis-diammine ...... carcinoma of the large bowel.
@en
Phase II study of cis-diamminedichloroplatinum
@nl
P2093
P1476
Phase II study of cis-diammine ...... carcinoma of the large bowel.
@en
P2093
A J Schutt
C G Moertel
J S Kovach
R G Reitemeier
P304
P577
1973-09-01T00:00:00Z